Different Pancreaticojejunostomy After Pancreaticoduodenectomy
Pancreaticoduodenectomy, Postoperative Pancreatic Fistula
About this trial
This is an interventional treatment trial for Pancreaticoduodenectomy focused on measuring pancreaticoduodenectomy, pancreaticojejunostomy, postoperative pancreatic fistula, pancreatic duct
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of benign or malignant peri-ampullary diseases
- The participants have age more than18 years
- The participants have adequate organ function to tolerate surgery
Exclusion Criteria:
*The participants undergoing other organ surgery at the same time
Sites / Locations
- Bole TianRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Experimental group
Control group
The experimental group underwent intraoperative measurements (A: short distance from the center of the pancreatic duct to the edge of the pancreas) and (B: pancreatic thickness). When the ratio of the thickness of the short distance from the center of the pancreatic duct to the edge of the pancreas at the pancreatic section was ≥0.401, it was divided into the N1 group (central pancreatic duct). If the ratio was <0.401, it was divided into the N2 group (eccentric pancreatic duct). The "central pancreatic duct" group was given "1+1 mode" pancreaticojejunostomy; the "eccentric pancreatic duct" group was given "1+1² mode" pancreaticojejunostomy.
The patients in the control group were given "traditional pancreaticojejunostomy"